Hyperammonemic coma: Beyond hepatic encephalopathy

Southern Medical Journal

Volumn 101, Issue 5, 2008, Pages 467-468

  Rimar, Doron ^a,b   Bitterman, Haim ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FLUOROURACIL; ORNITHINE CARBAMOYLTRANSFERASE;

BRAIN EDEMA; CANCER CHEMOTHERAPY; COMA; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; EDITORIAL; ENZYME ACTIVITY; GENE MUTATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC COMA; HYPOTHYROIDISM; LIVER CELL CARCINOMA; LIVER DISEASE; NEUROTOXICITY; PROTEIN SYNTHESIS; TREATMENT OUTCOME; UREA CYCLE;

HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE;

EID: 43149113431     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31816bea53     Document Type: Editorial

References (5)

1. Chan JS, Harding CO, Blanke CD. Post-chemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency. South Med J In press.
2. Winter SS, Rose E, Katz R. Hyperammonemia after chemotherapy in an adolescent with hepatocellular carcinoma. J Pediatr Gastroenterol Nutr 1997;25:537-540.
3. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006;44:788-794.
4. Rimar D, Kruzel-Davila E, Dori G, et al. Hyperammonemic coma - barking up the wrong tree. J Gen Intern Med 2007;22:549-552.
5. Nott L, Price TJ, Pittman K, et al. Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy. Leukemia Lymphoma 2007;48:1702-1711.